PTCT research notebook

SEC submissions · retrieved 2026-10-23 · 8022 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

1. 2026-10-16
   4 · Ownership change

   Report date 2026-10-14 · 0001288952-26-000016

2. 2026-10-13
   4 · Ownership change

   Report date 2026-10-09 · 0001578852-26-000026

3. 2026-10-09
   4 · Ownership change

   Report date 2026-10-07 · 0001288952-26-000014

4. 2026-10-07
   4 · Ownership change

   Report date 2026-10-05 · 0001578852-26-000024

5. 2026-10-02
   4 · Ownership change

   Report date 2026-09-30 · 0001269131-26-000005

6. 2026-09-21
   8-K · Current report

   Report date 2026-09-21 · 0001070081-26-000023 · Items 7.01,8.01,9.01

7. 2026-09-18
   4 · Ownership change

   Report date 2026-09-16 · 0001288952-26-000012

8. 2026-09-11
   4 · Ownership change

   Report date 2026-09-09 · 0001288952-26-000008

9. 2026-08-28
   4 · Ownership change

   Report date 2026-08-26 · 0001288952-26-000006

10. 2026-08-28
    8-K · Current report

    Report date 2026-08-25 · 0001070081-26-000019 · Items 1.01

11. 2026-08-13
    8-K · Current report

    Report date 2026-08-12 · 0001104659-26-095424 · Items 7.01,8.01,9.01

12. 2026-07-30
    10-Q · Quarterly report

    Report date 2026-06-30 · 0001070081-26-000017

13. 2026-07-30
    8-K · Current report

    Report date 2026-07-28 · 0001070081-26-000016 · Items 2.02,5.02,7.01,9.01

14. 2026-06-18
    8-K · Current report

    Report date 2026-06-18 · 0001104659-26-075731 · Items 1.01,2.03,3.02,8.01,9.01

15. 2026-06-16
    8-K · Current report

    Report date 2026-06-15 · 0001104659-26-074292 · Items 8.01,9.01

16. 2026-06-09
    8-K · Current report

    Report date 2026-06-08 · 0001104659-26-071916 · Items 5.02,9.01

17. 2026-06-05
    8-K · Current report

    Report date 2026-06-02 · 0001104659-26-071040 · Items 5.07

18. 2026-05-07
    10-Q · Quarterly report

    Report date 2026-03-31 · 0001070081-26-000012

19. 2026-05-07
    8-K · Current report

    Report date 2026-05-07 · 0001070081-26-000011 · Items 2.02,7.01,9.01

20. 2026-04-28
    8-K · Current report

    Report date 2026-04-28 · 0001070081-26-000006 · Items 7.01,9.01

21. 2026-04-20
    DEF 14A · Proxy statement

    Report date 2026-06-02 · 0001104659-26-045528

22. 2026-03-25
    8-K · Current report

    Report date 2026-03-24 · 0001104659-26-034207 · Items 5.02,7.01,9.01

23. 2026-02-19
    10-K · Annual report

    Report date 2025-12-31 · 0001104659-26-017575

24. 2026-02-19
    8-K · Current report

    Report date 2026-02-19 · 0001104659-26-017546 · Items 2.02,7.01,9.01

25. 2026-02-12
    8-K · Current report

    Report date 2026-02-12 · 0001104659-26-014414 · Items 7.01,9.01

26. 2026-01-12
    8-K · Current report

    Report date 2026-01-12 · 0001104659-26-002799 · Items 2.02,7.01,9.01

27. 2025-12-29
    8-K · Current report

    Report date 2025-12-29 · 0001104659-25-124837 · Items 1.01

28. 2025-11-04
    10-Q · Quarterly report

    Report date 2025-09-30 · 0001070081-25-000028

29. 2025-11-04
    8-K · Current report

    Report date 2025-11-04 · 0001070081-25-000026 · Items 2.02,7.01,9.01

30. 2025-08-19
    8-K · Current report

    Report date 2025-08-19 · 0001558370-25-011658 · Items 7.01,9.01

31. 2025-08-07
    10-Q · Quarterly report

    Report date 2025-06-30 · 0001558370-25-010796

32. 2025-08-07
    8-K · Current report

    Report date 2025-08-05 · 0001558370-25-010786 · Items 1.01

33. 2025-08-07
    8-K · Current report

    Report date 2025-08-07 · 0001558370-25-010770 · Items 2.02,7.01,9.01

34. 2025-07-28
    8-K · Current report

    Report date 2025-07-28 · 0001558370-25-009663 · Items 7.01,9.01

35. 2025-06-17
    8-K · Current report

    Report date 2025-06-17 · 0001558370-25-008694 · Items 5.07

36. 2025-05-06
    10-Q · Quarterly report

    Report date 2025-03-31 · 0001070081-25-000019

37. 2025-05-06
    8-K · Current report

    Report date 2025-05-06 · 0001070081-25-000018 · Items 2.02,7.01,9.01

38. 2025-05-05
    8-K · Current report

    Report date 2025-05-05 · 0001070081-25-000014 · Items 7.01,9.01

39. 2025-04-30
    DEF 14A · Proxy statement

    Report date 2025-06-17 · 0001558370-25-006007

40. 2025-03-28
    8-K · Current report

    Report date 2025-03-28 · 0001104659-25-029124 · Items 7.01,9.01

SEC insider transactions · retrieved 2026-10-23 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

63 matching transaction rows. Showing 51 to 63.

Identity & relationships

Wikidata structured data · retrieved 2026-10-23 · 1658 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier

549300UJLWOIWFDGB318

GLEIF legal name

PTC THERAPEUTICS, INC.

Entity / LEI registration status

ACTIVE / ISSUED

Reference data updated

2026-07-15T04:30:13Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-10-23 · 1197 checked identities; 0 unavailable records

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Bureau of Labor Statistics · retrieved 2026-10-23 · 9 selected series; gaps remain missing